MedtechWomen today announced that K. Angela Macfarlane, managing member and CEO of ForSight Labs, has been named the recipient of the third annual Ferolyn Powell Leadership Award at the organization’s MedtechVision 2017 conference.
Established in 2015, the award recognizes a leader who embodies persistence, passion, dedication to innovation and patients, and commitment to mentoring others in the medical technology sector. Ferolyn Powell, a leader in the medical device industry and a mentor to young entrepreneurs, was recognized with the first award posthumously, which was named in her honor.
“Ferolyn was a powerful and dedicated force in our industry, and an important catalyst in shaping my leadership path,” said Angela. “I am deeply honored and humbled to be recognized in her name by the MedtechWomen community.”
Angela brings broad experience in early stage company development to create a community of innovation focused on improving the lives of the visually impaired. Over the past 12 years, ForSight has incubated six vision companies, including Transcend Medical, Inc. (acquired by Alcon), ForSight Newco II (acquired by QLT), NexisVision (out-licensed), ForSight VISION4, (acquired by Roche), ForSight VISION5 (acquired by Allergan) and ForSight VISION6 (private).
Prior to joining the ForSight Labs team full-time, Angela served as chief technology counsel to The Foundry, a medical device incubator. Her previous experience includes serving as technology counsel for Thomas J. Fogarty, M.D., and senior management team roles at several medical technology start-up companies. She received her B.A. in Business Administration from San Francisco State University, and J.D. from Golden Gate University.
“Angela’s impact on the medtech community through dynamic and inspiring leadership makes her a clear choice for the Ferolyn Powell Leadership Award,” said Deborah Kilpatrick, Ph.D., MedtechWomen co-founder and CEO of Evidation Health. “And true to the spirit of this award, Angela is broadly recognized as a leader who develops others around her, wherever she goes.”
“Ferolyn was a connector of bright minds – she loved to bring the right people together to move an important idea or new product forward. Angela has demonstrated unlimited energy for linking people and ideas and her dedication to mentoring talented leaders makes her admirable choice for this award,” said Liz McDermott, co-founder of the Ferolyn Fellowship, which provides mentoring to innovators who exemplify strong leadership with an emphasis on female entrepreneurs.
Ferolyn Powell made an indelible impression not only as an individual in her San Francisco community, but also globally, as a business leader and innovator. She was best known as president and CEO of Evalve, Inc., a start-up medical device company founded in 1999. Under her leadership Evalve was acquired by Abbott. Ferolyn oversaw the development and commercialization of the MitraClip® System, a breakthrough technology to repair the leaky heart valves of patients with mitral regurgitation, a common heart condition, without invasive open-heart surgery. One of a handful of women CEOs, Ferolyn was generous with her time, mentoring young entrepreneurs through the Stanford Biodesign Program, now known as the Stanford Byers Center for Biodesign.
Kimberly Popovits, chairman of the Board, CEO and president of Genomic Health, was the recipient of the 2016 Ferolyn Powell Leadership Award.
MedtechWomen is a 510(c)(3) educational nonprofit organization dedicated to highlighting and connecting women leaders in medical devices and diagnostics. The organization was founded in 2010 when a group of women acted on their vision of bringing together sector leaders and policymakers to discuss real-world solutions to the most challenging issues in the medical technology industry today. They enlisted the support of their mentors and a broadening circle of colleagues to bring this vision to reality, resulting in the inaugural MedtechVision conference in 2011.
Founders and organizing members of MedtechWomen are innovators from across the U.S. in varied aspects of the medtech sector including business leaders, financial investors, researchers, physicians and experts in new product commercialization. For more information please visit www.medtechwomen.org.
Nicole Osmer, 650-454-0504